|EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda|
S Aggarwal, S Negi, P Jha, PK Singh, T Stobdan, MAQ Pasha, S Ghosh, ...
Proceedings of the National Academy of Sciences 107 (44), 18961-18966, 2010
|Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment|
M Gupta, P Bhatnagar, S Grover, H Kaur, R Baghel, Y Bhasin, C Chauhan, ...
Future Medicine Ltd 10 (3), 385-397, 2009
|Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease|
P Talwar, Y Silla, S Grover, M Gupta, R Agarwal, S Kushwaha, R Kukreti
BMC genomics 15 (1), 1-16, 2014
|HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis|
S Grover, R Kukreti
Pharmacogenetics and genomics 24 (2), 94-112, 2014
|Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms|
M Gupta, C Chauhan, P Bhatnagar, S Gupta, S Grover, PK Singh, ...
Future Medicine Ltd 10 (2), 277-291, 2009
|Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients|
S Grover, K Bala, S Sharma, M Gourie-Devi, R Baghel, H Kaur, M Gupta, ...
Biochimie 92 (9), 1207-1212, 2010
|Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment|
S Grover, M Gourie-Devi, R Baghel, S Sharma, K Bala, M Gupta, ...
Pharmacogenomics 11 (7), 927-941, 2010
|Dissecting complex and multifactorial nature of Alzheimer’s disease pathogenesis: a clinical, genomic, and systems biology perspective|
P Talwar, J Sinha, S Grover, C Rawat, S Kushwaha, R Agarwal, V Taneja, ...
Molecular neurobiology 53 (7), 4833-4864, 2016
|A systematic review and meta‐analysis of the role of ABCC2 variants on drug response in patients with epilepsy|
S Grover, R Kukreti
Epilepsia 54 (5), 936-945, 2013
|Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population|
AK Giri, NM Khan, S Grover, I Kaur, A Basu, N Tandon, V Scaria, ...
Pharmacogenomics 15 (10), 1337-1354, 2014
|Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs|
S Grover, M Gourie-Devi, K Bala, S Sharma, R Kukreti
Pharmacogenetics and genomics 22 (6), 447-465, 2012
|Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease|
P Talwar, J Sinha, S Grover, R Agarwal, S Kushwaha, MVP Srivastava, ...
Journal of the neurological sciences 360, 179-187, 2016
S Grover, M Fabiola Del Greco, CM Stein, A Ziegler
Statistical Human Genetics, 581-628, 2017
|Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy|
S Grover, P Talwar, M Gourie-Devi, M Gupta, K Bala, S Sharma, R Baghel, ...
Pharmacogenomics 11 (11), 1525-1534, 2010
|Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of …|
H Kaur, A Jajodia, S Grover, R Baghel, S Jain, R Kukreti
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165 …, 2014
|Multifactorial analysis of a biomarker pool for Alzheimer disease risk in a North Indian population|
P Talwar, S Grover, J Sinha, P Chandna, R Agarwal, S Kushwaha, ...
Dementia and geriatric cognitive disorders 44 (1-2), 25-34, 2017
|Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients|
H Kaur, A Jajodia, S Grover, R Baghel, M Gupta, S Jain, R Kukreti
PLoS One 9 (7), e102556, 2014
|Genetic studies indicate a potential target 5‐HTR3B for Drug Therapy in Schizophrenia Patients|
M Gupta, S Jain, NS Moily, H Kaur, A Jajodia, M Purushottam, R Kukreti
American Journal of Medical Genetics-Neuropsych Genetics Part B 159 (8), 1006, 2012
|Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective|
P Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, ...
The pharmacogenomics journal 17 (3), 242-251, 2017
|Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics|
S Grover, M Gupta, R Kukreti
Indian journal of human genetics 17 (Suppl 1), S4, 2011